Pharmaceutical Automation Market to be Worth $25.11 Billion by 2031
Meticulous Research®—a
leading global market research company, published a research report titled, ‘Pharmaceutical
Automation Market – Global Opportunity Analysis and Industry Forecasts
(2024- 2031)’. According to this latest publication from Meticulous
Research®, the pharmaceutical automation market is projected to
reach $25.11
billion by 2031, at a CAGR of 10.8% from 2024 to 2031. The growth
of the global pharmaceutical automation market is fueled by the rising adoption
of robots in pharmaceutical manufacturing, government initiatives to support
industrial automation, and increasing demand for energy-efficient systems.
However, the high capital expenditure (CAPEX) required may hinder market
growth.
Furthermore, the
rising demand for IIoT in pharmaceutical manufacturing is expected to generate
growth opportunities for the stakeholders in this market. However, the lack of
availability of a skilled workforce and cybersecurity risk associated with automated
systems is a major challenge impacting the market growth.
Key Players:
Some of the key
players operating in the pharmaceutical automation market are Siemens AG
(Germany), Emerson Electric (U.S.), Mitsubishi Electric Corporation (Japan),
ABB Ltd (Switzerland), FANUC CORPORATION (Japan), Honeywell International Inc.
(U.S.), KUKA AG (Germany), Schneider Electric SE (France), Rockwell Automation,
Inc. (U.S.), YASKAWA Electric Corporation (Japan), Yokogawa Electric
Corporation (Japan), General Electric Company (U.S.), OMRON Corporation
(Japan), Advantech Co., Ltd. (Taiwan), and Fuji Electric Co., Ltd. (Japan).
Key Drivers Fueling
the Growth of the Pharmaceutical Automation Market:
Pharmaceutical
automation has experienced remarkable momentum in recent years. The primary
catalysts behind this surge include the rapid adoption of robotics in
pharmaceutical manufacturing, robust government initiatives fostering
industrial automation, and an urgent need for energy-efficient systems.
Robotics now permeate a wide array of pharmaceutical applications—from
cleanroom repetitive tasks to precision quality control—reducing contamination
risks and helping companies comply with stringent industry standards.
Additionally, the
emergence of Industry 4.0 and the growing integration of smart manufacturing
tools like artificial intelligence, machine vision, and predictive analytics
are significantly amplifying the market’s potential. Governments across major
economies, including those in Europe and Asia, are actively supporting the
deployment of disruptive technologies in the pharmaceutical sector via tax
incentives, R&D grants, and promotional programs.
Recent real-world
implementations underscore these trends. For example, Sinocare’s adoption of
Autonomous Case-handling Robot (ACR) Systems in partnership with HAI ROBOTICS
has showcased the productivity and cost savings realized through end-to-end
warehouse automation. Moreover, leading automation players such as Siemens,
ABB, and Honeywell International consistently invest in R&D to keep pace
with the industry’s evolving demands.
The Impact of IoT
and Emerging Technologies in Pharmaceutical Manufacturing:
Emerging technologies
like the Industrial Internet of Things (IIoT) have emerged as game changers for
pharmaceutical manufacturing. IIoT platforms bridge the gap between data silos,
enhance real-time monitoring, and support predictive maintenance—all contributing
to higher productivity and compliance.
Manufacturers now
harness IIoT to streamline the pharmaceutical value chain, from drug research
and discovery to distribution and patient monitoring. Leveraging IIoT,
companies can remotely monitor machine settings, track downtime, and analyze
performance metrics, fundamentally transforming operations and feedback loops.
An example is ACG’s rollout of Smart Connected Product in India, which connects
production machines and visualizes manufacturing data across secure platforms
accessible from virtually anywhere.
With IIoT solutions,
pharmaceutical companies not only address traditional challenges—such as
connectivity gaps, process inefficiencies, and regulatory complexities—but also
rapidly accelerate the delivery of high-quality medicines to the market. The
march towards “Pharma 4.0,” fueled by digital transformation and real-time
analytics, promises enhanced drug safety, improved transportation logistics,
and streamlined compliance with global pharmaceutical vigilance protocols.
Regional Trends
Shaping Market Opportunities:
Geography plays a
distinct role in shaping the pharmaceutical automation market’s growth
trajectory. As of 2024, Europe commands the largest share—32.9%—of the global
pharmaceutical automation market, fueled by advanced digitalization initiatives
and robust adoption of Industry 4.0 technologies. The region’s focus on
efficiency, waste reduction, and pharmaceutical quality has prompted leading
players to invest heavily in automation and intelligent process technologies.
Asia-Pacific, however,
represents the fastest-growing region, with an impressive CAGR of 11.8%
projected through 2031. This growth stems from a convergence of factors: rapid
modernization of pharmaceutical manufacturing facilities, escalating
investments in technology, and a heightened emphasis on robotics and automation
to boost output and competitiveness. Countries such as China, Japan, and India
are not only increasing their investments in automation but also leveraging
government-backed incentives for industry research and transformation.
Download Free Sample PDF Copy: https://www.meticulousresearch.com/download-sample-report/cp_id=5280
Key questions
answered in the report-
- Which are the high-growth market segments
based on offering, mode of automation, and end user?
- What was the historical market for
pharmaceutical automation?
- What are the market forecasts and
estimates for the period 2024–2031?
- What are the major drivers, restraints,
and opportunities in the pharmaceutical automation market?
Contact Us:
Meticulous Research®
Email- sales@meticulousresearch.com
Contact Sales- +1-646-781-8004
Connect with us on LinkedIn- https://www.linkedin.com/company/meticulous-research
Comments
Post a Comment